GlucoTrack (GCTK) vs Beyond Air (XAIR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Beyond Air is the larger company by market cap ($2.2 million vs $1.0 million), about 2.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GCTK | XAIR |
|---|---|---|
| Share price | $1.03 | $2.25 |
| Market cap | $1.05M | $2.21M |
| 1-day change | -7.21% | -2.60% |
| EPS (TTM) | $-123.15 | $-64.40 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $123.75 | $55.00 |
| 52-week low | $1.00 | $2.20 |
| Distance from 52-week high | -99.17% | -95.91% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +788.89% |
| Average volume | 2.06M | 222.52K |
| Shares outstanding | 1.02M | 984.41K |
| Employees | 15 | 54 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Beyond Air is about 2.1 times larger than GlucoTrack by market value ($2.21M vs $1.05M).
About GlucoTrack
GCTK stock →GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.
Health Care · Medical/Dental Instruments · 15 employees
About Beyond Air
XAIR stock →Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company.
Health Care · Medical/Dental Instruments · 54 employees
GCTK vs XAIR FAQ
Which is bigger, GlucoTrack or Beyond Air?
Beyond Air (XAIR) is larger, with a market capitalization of $2.21M compared with $1.05M for GlucoTrack (GCTK).
Are GlucoTrack and Beyond Air in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.